成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 849217-68-1 Chemical Structure| 849217-68-1
Chemical Structure| 849217-68-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 849217-68-1

,{[proInfo.pro_purity]}

Cabozantinib is a potent and orally active inhibitor of VEGFR2 and MET, with IC50 values of 0.035 and 1.3 nM, respectively. It also strongly inhibits KIT, RET, AXL, TIE2, and FLT3, with IC50 values of 4.6, 5.2, 7, 14.3, and 11.3 nM, respectively. Cabozantinib shows antiangiogenic activity, disrupts tumor vasculature, and promotes tumor and endothelial cell apoptosis.

Synonyms: XL184; BMS-907351

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Cabozantinib

CAS No. :849217-68-1
Formula : C28H24FN3O5
M.W : 501.51
SMILES Code : O=C(C1(C(NC2=CC=C(F)C=C2)=O)CC1)NC3=CC=C(OC4=CC=NC5=CC(OC)=C(OC)C=C45)C=C3
Synonyms :
XL184; BMS-907351
InChI Key :ONIQOQHATWINJY-UHFFFAOYSA-N
Pubchem ID :25102847

Safety of Cabozantinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H320-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of Cabozantinib

RTK

Isoform Comparison

Biological Activity

Target
  • VEGFR2

    VEGFR2/KDR, IC50:0.035 nM

In Vitro:

Cell Line
Concentration Treated Time Description Reference
HCT116 cells 5 μM 24 h To evaluate the effect of Cabozantinib on autophagy, results showed that Cabozantinib significantly induced autophagy. PMC6168336
HT29 cells 5 μM 24 h To evaluate the effect of Cabozantinib on autophagy, results showed that Cabozantinib significantly induced autophagy. PMC6168336
2H11 cells 1 μM 20 h To evaluate the effect of Cabozantinib on tube formation in 2H11 cells, results showed that Cabozantinib inhibited tube formation. PMC9444986
H460/MX20 5 μM 72 h Cabozantinib significantly sensitized H460/MX20 cells to ABCG2 substrate drugs (such as mitoxantrone, SN-38, and topotecan), reversing ABCG2-mediated multidrug resistance. PMC5392419
ABCG2-482-R2 5 μM 72 h Cabozantinib significantly sensitized ABCG2-482-R2 cells to ABCG2 substrate drugs (such as mitoxantrone, SN-38, and topotecan), reversing ABCG2-mediated multidrug resistance. PMC5392419
ABCG2-482-G2 5 μM 72 h Cabozantinib significantly sensitized ABCG2-482-G2 cells to ABCG2 substrate drugs (such as mitoxantrone, SN-38, and topotecan), reversing ABCG2-mediated multidrug resistance. PMC5392419
ABCG2-482-T7 5 μM 72 h Cabozantinib significantly sensitized ABCG2-482-T7 cells to ABCG2 substrate drugs (such as mitoxantrone, SN-38, and topotecan), reversing ABCG2-mediated multidrug resistance. PMC5392419
JHH5 cells 3 μM 72 h To evaluate the inhibitory effect of Cabozantinib on JHH5 cells, results showed that Cabozantinib alone only partially interfered with cell viability PMC9700715
Hep3B cells 3 μM 72 h To evaluate the inhibitory effect of Cabozantinib on Hep3B cells, results showed that Cabozantinib alone only partially interfered with cell viability PMC9700715
Huh7 cells 3 μM 72 h To evaluate the inhibitory effect of Cabozantinib on Huh7 cells, results showed that Cabozantinib alone only partially interfered with cell viability PMC9700715
SC1 cells 10 μM 24 h To detect the release of CXCL12 after Cabozantinib treatment, the results showed that Cabozantinib treatment significantly increased the release of CXCL12. PMC5501767
SC1 cells 10 μM 28 h To detect the release of HMGB1 after Cabozantinib treatment, the results showed that Cabozantinib treatment significantly increased the release of HMGB1. PMC5501767
HCT116 cells 5 μM 24 h To evaluate the effect of Cabozantinib on autophagy, results showed that Cabozantinib significantly induced autophagy PMC6168336
HT29 cells 5 μM 24 h To evaluate the effect of Cabozantinib on autophagy, results showed that Cabozantinib significantly induced autophagy PMC6168336

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
NOD/SCID mice Peritoneal dissemination model Intraperitoneal injection 30 mg/kg 5 times per week for 15 days To evaluate the antitumor efficacy of cabozantinib as monotherapy or in combination with nal-IRI in gastric cancer mouse models. Results showed that cabozantinib monotherapy significantly extended animal survival (24 days, a 33% increase), and its combination with nal-IRI further extended survival (50 days, a 178% increase). PMC9377761
Nude mice Colorectal cancer patient-derived xenograft model Oral 30 mg/kg Daily for 28 days To evaluate the antitumor effects of Cabozantinib in colorectal cancer xenograft models, results showed that Cabozantinib significantly inhibited tumor growth. PMC6168336
mice ccRCC tumor xenograft model oral gavage 10mg/kg daily Cabozantinib significantly reduced the tumor growth of the ccRCC M62 tumor xenografts. PMC7015045
mice PTEN/p53 deficient prostate cancer model oral 100 mg/kg once daily for 3 weeks Cabozantinib significantly reduced tumor volume and nearly completely cleared poorly differentiated prostate cancer within 4 days. PMC5501767
Mice Colorectal cancer patient-derived xenograft model Oral 30 mg/kg Once daily for 28 days To evaluate the antitumor effects of Cabozantinib in colorectal cancer xenograft models, results showed that Cabozantinib significantly inhibited tumor growth and reduced tumor vascularity PMC6168336

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05135975 Neuroblastoma|Sarcoma PHASE2 RECRUITING 2025-12-29 Children's Hospital of Alabama... More >>/UAB, Birmingham, Alabama, 35233, United States|Children's Hospital of Colorado, Aurora, Colorado, 80045, United States|Children's National Medical Center, Washington, District of Columbia, 20010, United States|Children's Hospital at Montefiore, Bronx, New York, 10467, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|Primary Children's Hospital, Salt Lake City, Utah, 84113, United States Less <<
NCT01755195 Refractory Soft Tissue Sarcoma... More >>s Less << PHASE2 COMPLETED 2023-09-11 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<
NCT06548867 Metastatic Renal Cell Carcinom... More >>a Less << RECRUITING 2025-06-30 AUSL-IRCCS of Reggio Emilia, R... More >>eggio Emilia, 42123, Italy Less <<
NCT05425004 Meningioma PHASE2 RECRUITING 2025-05-28 Miami Cancer Institute at Bapt... More >>ist Health, Inc., Miami, Florida, 33176, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 100653, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States Less <<
NCT05265988 Carcinoma Prostate PHASE2 COMPLETED 2024-06-29 Alfredo Berruti, Brescia, 2512... More >>3, Italy Less <<
NCT00215605 Lymphoma|Cancer|Thyroid Carcin... More >>oma Less << PHASE1 COMPLETED 2025-07-12 University of Chicago, Chicago... More >>, Illinois, 60637, United States|Johns Hopkins University, Baltimore, Maryland, 21231, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10021, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Univ. of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States Less <<
NCT03911193 Non-Small Cell Lung Cancer PHASE2 UNKNOWN 2025-09-20 A.O. "S.Giuseppe Moscati", Ave... More >>llino, AV, 83100, Italy|IRCCS Oncologico Giovanni Paolo II, Bari, BA, 70124, Italy|A.O.U. Careggi, Firenze, FI, 50134, Italy|Irccs Irst, Meldola, FO, 47014, Italy|Ospedale Infermi Rimini, Rimini, FO, 47923, Italy|A.O. Papardo, Messina, ME, 98158, Italy|Istituto Europeo di Oncologia, Milano, MI, 20141, Italy|Ospedale San Gerardo, Monza, MI, 20900, Italy|AOU Policlinico di Modena, Modena, MO, 41124, Italy|Casa di Cura La Maddalena, Palermo, PA, 90146, Italy|Istituto Oncologico Veneto, Padova, PD, 35128, Italy|A.O. S.M. Misericordia, Perugia, PG, 06129, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, PI, 56124, Italy|Azienda Ospedaliero- Universitaria di Parma, Parma, PR, 43126, Italy|AUSL Reggio Emilia- IRCCS Arcispedale S.M. Nuova, Reggio Emilia, RE, 42123, Italy|Fondazione Policlinico Gemelli, Roma, RM, 00168, Italy|Istituto Nazionale Tumori Regina Elena, Roma, RO, 00144, Italy|A.O.U. S. Luigi Gonzaga, Orbassano, Torino, 10043, Italy|AUSL della Romagna, Ravenna, Italy|Azienda Ospedaliero Universitaria Integrata di Verona, Verona, 37134, Italy Less <<
NCT04588051 HCC PHASE2 ACTIVE_NOT_RECRUITING 2027-12-31 Department of Clinical Oncolog... More >>y, Prince of Wales Hospital, Hong Kong, Hong Kong|ASAN Medical Center, Seoul, Korea, Republic of Less <<
NCT03967522 Metastatic Renal Cell Carcinom... More >>a Less << PHASE2 COMPLETED 2024-11-01 Institut de Cancérologie de l'... More >>Ouest-Site Paul Papin, Angers, 49005, France|CHU Besancon, Besan?on, 25030, France|CHU Bordeaux, Bordeaux, 33075, France|Centre Jean Perrin, Clermont-Ferrand, 63011, France|Centre Leon Berard, Lyon, 69373, France|Institut de Cancérologie de la Lorraine, Nancy, 54519, France|Hopital Européen Georges Pompidou, Paris, 75015, France|Institut de Cancérologie de l'Ouest-site René Gauducheau, Saint-Herblain, 44805, France|ICANS, Strasbourg, 67000, France|Hopital Foch, Suresnes, 92150, France|IUCT-Institut Claudius Regaud, Toulouse, 31059, France|Institut Gustave Roussy, Villejuif, 94805, France Less <<
NCT01428219 Prostate Cancer Metastatic PHASE2 TERMINATED 2025-09-15 University of Michigan, Ann Ar... More >>bor, Michigan, 48109, United States Less <<
NCT03729297 Salivary Gland Cancer PHASE2 TERMINATED 2019-11-06 Radboudumc, Nijmegen, Gelderla... More >>nd, 6500HB, Netherlands Less <<
NCT02036476 Merkel Cell Carcinoma|Skin Can... More >>cer Less << PHASE2 TERMINATED 2025-07-16 Brigham and Women's Hospital, ... More >>Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States Less <<
NCT01738438 Breast Cancer PHASE2 COMPLETED 2025-05-15 Dana-Farber Cancer Institute a... More >>t Faulkner Hospital, Boston, Massachusetts, 02130, United States|Massachusetts General Hospital, Boston, Massachusetts, 02214, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States Less <<
NCT01582295 Multiple Myeloma PHASE1 COMPLETED 2025-11-14 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States Less <<
NCT04497038 Advanced Adult Hepatocellular ... More >>Carcinoma Less << PHASE1|PHASE2 TERMINATED 2023-05-02 Northwestern University, Chica... More >>go, Illinois, 60611, United States|University of Chicago, Chicago, Illinois, 60637, United States|University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, 48109, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States Less <<
NCT04066595 Urothelial Carcinoma PHASE2 TERMINATED 2021-07-01 Department of Urology of the U... More >>niversity Medical Center Mainz, Mainz, 55131, Germany Less <<
NCT04631744 Prostate Cancer PHASE2 RECRUITING 2025-07-27 Karmanos Cancer Institute, Det... More >>roit, Michigan, 48201, United States|Columbia University Irving Medical Center, New York, New York, 10032, United States|Weill Cornell Medicine, New York, New York, 10065, United States|University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, 15232, United States Less <<
NCT06535737 Hepatocellular Carcinoma Non-r... More >>esectable Less << PHASE2 NOT_YET_RECRUITING 2025-12-26 -
NCT01068782 Astrocytic Tumors PHASE2 COMPLETED 2025-10-13 Birmingham, Alabama, 35294, Un... More >>ited States|Encinitas, California, 92024, United States|Pleasant Hill, California, 94523, United States|Chicago, Illinois, 60611, United States|Chicago, Illinois, 60637, United States|Boston, Massachusetts, 02115, United States|Detroit, Michigan, 48202, United States|Minneapolis, Minnesota, 55407, United States|Amhearst, New York, 14226, United States|Rochester, New York, 14642, United States|Cleveland, Ohio, 44195, United States|Hershey, Pennsylvania, 17033, United States|Dallas, Texas, 75246, United States|Dallas, Texas, 75426, United States|San Antonio, Texas, 78229, United States|Charlottesville, Virginia, 22908, United States|Seattle, Washington, 98122, United States|Calgary, Alberta, Canada|Montreal, Quebec, Canada Less <<
NCT03586973 Advanced Hepatocellular Carcin... More >>oma Less << PHASE2 COMPLETED 2021-06-29 Aichi Cancer Center Hospital, ... More >>Nagoya, Aichi, Japan|National Cancer Center Hospital East, Kashiwa, Chiba, Japan|Iizuka Hospital, Iizuka, Fukuoka, Japan|Kurume University Hospital, Kurume, Fukuoka, Japan|Sapporo-Kosei General Hospital, Sapporo, Hokkaido, Japan|Kanazawa University Hospital, Kanazawa, Ishikawa, Japan|Kanagawa Cancer Center, Yokohama, Kanagawa, Japan|Yokohama City University Medical Center, Yokohama, Kanagawa, Japan|Kindai University Hospital, Osakasayama, Osaka, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, Japan|Kyorin University Hospital, Mitaka, Tokyo, Japan|Japanese Red Cross Musashino Hospital, Musashino, Tokyo, Japan|Chiba University Hospital, Chiba, Japan|Hiroshima University Hospital, Hiroshima, Japan|Okayama University Hospital, Okayama, Japan|Osaka City University Hospital, Osaka, Japan|Osaka International Cancer Institute, Osaka, Japan Less <<
NCT03943602 Penile Squamous Cell Carcinoma PHASE2 UNKNOWN 2022-09-01 Fondazione IRCCS Istituto Nazi... More >>onale dei Tumori, Milano, 20133, Italy Less <<
NCT00704288 Glioblastoma Multiforme PHASE2 COMPLETED 2025-12-12 University of California, Los ... More >>Angeles, Los Angeles, California, 90095, United States|University of California, San Francisco, San Francisco, California, 94143, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Duke University, The Preston Robert Tisch Brain Tumor Center, Durham, North Carolina, 27710, United States|University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030, United States|University of Virginia Health System, Charlottesville, Virginia, 22908, United States|University of Washington, Seattle, Washington, 98195, United States Less <<
NCT04205799 Advanced/Metastatic Cervical C... More >>ancer Less << PHASE2 COMPLETED 2023-01-15 Institut de cancérologie de l'... More >>Ouest, Angers, France|Centre Fran?ois Baclesse, Caen, France|Centre Oscar LAMBRET, Lille, France|Centre Léon Bérard, Lyon, France|Institut de Cancérologie de Montpellier, Montpellier, France|Institut de cancérologie de l'Ouest, Nantes, France|Institut CURIE, Saint-Cloud, France|Institut Gustave Roussy, Villejuif, France Less <<
NCT04022343 Clear Cell Renal Cell Carcinom... More >>a|Renal Cell Carcinoma|Stage III Renal Cell Cancer AJCC v8 Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-02-02 Emory University Hospital/Wins... More >>hip Cancer Institute, Atlanta, Georgia, 30322, United States Less <<
NCT01954745 Bile Duct Cancer|Intrahepatic ... More >>Cholangiocarcinoma|Cholangiocarcinoma of the Extrahepatic Bile Duct Less << PHASE2 COMPLETED 2025-06-16 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States Less <<
NCT04416646 Renal Cell Carcinoma ACTIVE_NOT_RECRUITING 2024-03-01 Istituto Oncologico Veneto, Pa... More >>dova, 35100, Italy Less <<
NCT02101736 NF1|Neurofibromatosis|Plexifor... More >>m Neurofibromas Less << PHASE2 COMPLETED 2022-02-16 Children's Hospital Los Angele... More >>s, Los Angeles, California, 90027, United States|Children's National Medical Center, Washington, District of Columbia, 20010, United States|Lurie Children's Hospital of Chicago, Chicago, Illinois, 60611, United States|University of Chicago, Chicago, Illinois, 60637, United States|Indiana Unversity, Indianapolis, Indiana, 46202, United States|National Cancer Institute (NCI), Bethesda, Maryland, 20892, United States|Children' Hospital Boston and Massachusetts General Hospital, Boston, Massachusetts, 02115, United States|Washington University - St. Louis, Saint Louis, Missouri, 63110, United States|New York University Medical Center, New York, New York, 10016, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19096, United States|University of Utah, Salt Lake City, Utah, 84132, United States Less <<
NCT02885324 Glioblastoma Multiforme|Anapla... More >>stic Astrocytoma|Malignant Brain Tumor|High Grade Glioma Less << PHASE2 TERMINATED 2020-08-25 Riley Hospital for Children at... More >> IU Health, Indianapolis, Indiana, 46202, United States Less <<
NCT04510688 Renal Cell Carcinoma COMPLETED 2022-06-30 Hospital Universitario Reina S... More >>ofía, Córdoba, Andalucía, 14004, Spain|Hospital Universitario Juan Ramón Jiménez, Huelva, Andalucía, 21005, Spain|Complejo Hospitalario de Jaén, Jaén, Andalucía, 23007, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, 33011, Spain|Hospital Universitari Parc Taulí, Sabadell, Barcelona, 08208, Spain|Hospital Universitario de León, León, Castilla Y León, 24008, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, 08041, Spain|Hospital Universitari Sant Joan de Reus, Reus, Catalunya, 43204, Spain|Consorci Corporació Sanitària Parc Taulí de Sabadell, Sabadell, Catalunya, 08208, Spain|Hospital Universitari i Politècnic La Fe, Valencia, Comunidad Valenciana, 46026, Spain|Hospital Clínico Universitario de Valenica, Valencia, Comunitat Valenciana, 46010, Spain|Hospital Universitari Dr. Peset, Valencia, Comunitat Valenciana, 46017, Spain|Hospital Universitario de Badajoz, Badajoz, Extremadura, 06080, Spain|Centro Oncológico de Galicia, A Coru?a, Galicia, 15009, Spain|Complejo Hospitalario Universitario de Ferrol, Ferrol, Galicia, 15405, Spain|Complejo Hospitalario Universitario Ourense, Ourense, Galicia, 32005, Spain|Hospital Universitari Son Espases, Palma De Mallorca, Illes Ballears, 07120, Spain|Hospital Son Llatzer, Palma De Mallorca, Islas Baleares, 07198, Spain|Hospital Unviersitario de Gran Canaria Doctor Negrin, Las Palmas De Gran Canaria, Islas Canarias, 35010, Spain|Hospital Universitario Nuestra Se?ora de Candelaria, Santa Cruz De Tenerife, Islas Canarias, 38010, Spain|Hospital Del Mar, Barcelona, 08003, Spain|Hospital Universitari Vall D'Hebron, Barcelona, 08035, Spain|Hospital Clínic de Barcelona, Barcelona, 08036, Spain|Hospital Universitario de Burgos, Burgos, 09006, Spain|Hospital Provincial de Castellón, Castellón De La Plana, 12002, Spain|Hospital General de Ciudad Real, Ciudad Real, 13005, Spain|Hospital San Pedro de Alcántara, Cáceres, 10003, Spain|Hospital Universitario Lucus Augusti, Lugo, 27003, Spain|Hospital Virgen de La Salud, Toledo, 45004, Spain|Fundación Instituto Valenciano de Oncología, Valencia, 46009, Spain|Hospital Arnau de Vilanova, Valencia, 46015, Spain|Hospital Universitario Alvaro Cunqueiro, Vigo, 36312, Spain Less <<
NCT06171854 Refractory Colorectal Adenocar... More >>cinoma Less << PHASE2 ACTIVE_NOT_RECRUITING 2024-12-31 A.O.U dell'Università degli St... More >>udi della Campania "Luigi Vanvitelli", Napoli, Italy Less <<
NCT04876456 Germ Cell Tumor|Seminoma|Non-s... More >>eminomatous Germ Cell Tumor|Ovarian Germ Cell Tumor Less << PHASE2 RECRUITING 2025-02-26 Indiana University Melvin & Br... More >>en Simon Cancer Center, Indianapolis, Indiana, 46202, United States Less <<
NCT06156410 Ewing Sarcoma|Osteosarcoma PHASE1 RECRUITING 2025-11-28 University of California San F... More >>rancisco, San Francisco, California, 94143, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States Less <<
NCT04316182 Hepatocellular Carcinoma PHASE2 COMPLETED 2023-02-22 Hospital Clinic, Barcelona, Sp... More >>ain|Hospital Vall d'Hebron, Barcelona, Spain|Institut Català D'Oncologia - Hospital Duran I Reynals, Barcelona, Spain|Hospital Puerta de Hierro, Madrid, Spain|Hospital Ramon y Cajal, Madrid, Spain|Hospital Central de Asturias, Oviedo, Spain Less <<
NCT04511455 Hepatocellular Carcinoma Non-r... More >>esectable|Metastatic Hepatocellular Carcinoma Less << PHASE2 COMPLETED 2024-12-31 Helios Klinikum Bad Saarow, Ba... More >>d Saarow, 15526, Germany|Universit?tsklinikum Halle (Saale), Halle, 06120, Germany|Medizinische Hochschule Hannover, Hannover, 30625, Germany|Universit?tsklinikum Schleswig-Holstein, Kiel, 24105, Germany|Universit?tsklinikum K?ln, K?ln, 50937, Germany|VK&K Studien, Landshut, 84036, Germany|Universit?tsklinikum Schleswig-Holstein, Lübeck, 23538, Germany|Klinikum rechts der Isar der Technischen Universit?t München, München, 81675, Germany|Johanna Etienne Krankenhaus, Neuss, 41462, Germany|Universit?tsklinikum Ulm, Ulm, 89081, Germany Less <<
NCT05660954 Differentiated Thyroid Cancer PHASE2 ACTIVE_NOT_RECRUITING 2025-06-25 Hospital Universitario Central... More >> de Asturias, Oviedo, Asturias, 33011, Spain|Hospital Universitario Rey Juan Carlos, Móstoles, Madrid, 28933, Spain|Complexo Hospitalario Universitario A Coru?a, A Coru?a, 15006, Spain|Hospital Universitario Vall d'Hebron, Barcelona, 08035, Spain|Hospital Clínic de Barcelona, Barcelona, 08036, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|Hospital Clínico San Carlos, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital General Universitario Morales Meseguer, Murcia, 30008, Spain|Complejo Asistencial Universitario de Salamanca, Salamanca, 37007, Spain Less <<
NCT03945773 Locally Advanced or Metastatic... More >> Renal Cell Carcinoma Less << PHASE2 ACTIVE_NOT_RECRUITING 2099-09-30 SALK - Salzburger Landesklinik... More >>, Salzburg, A-5020, Austria|CHRU Besan?on, Besan?on, 25000, France|Centre Jean Perrin, Clermont-Ferrand, 63011, France|Centre Léon Bérard, Lyon, 69008, France|Institut Paoli Calmettes, Marseille, 13009, France|Institut de Cancérologie de Lorraine, Nancy, 54511, France|CHU de N?mes - Institut de Cancérologie du Gard, N?mes, 30029, France|Institut Mutualiste Montsouris, Paris, 75014, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, 69495, France|Institut de Cancérologie de l'Ouest, Saint-Herblain, 44800, France|CHU Strasbourg, Strasbourg, 67091, France|Institut Claudius Régaud, Toulouse, 31059, France|Gustave Roussy, Villejuif, 94805, France|Universit?tsmedzin Charité, Berlin, D-10117, Germany|University Hospital Carl Gustav Carus Dresden, Dresden, D-1307, Germany|Universit?tsklinikum Essen, Essen, D-45147, Germany|University Cancer Center Hamburg Eppendorf, Hamburg, d-20246, Germany|Medizinische Hochschule Hannover, Hannover, D-30625, Germany|Klinikum Der Friedrich-Schiller-Universitaet Jena, Jena, D-07747, Germany|Universit?tsklinikum Schleswig-Holstein, Lübeck, D-23538, Germany|Otto-von-Guericke-Universit?t University hospital Magdeburg, Magdeburg, D-39120, Germany|University, Hospital Münster, Münster, D-48149, Germany|Caritas Krankenhaus St.Josef Klinik für Urologie, Regensburg, D-93053, Germany|University Hospital Tuebingen, Tübingen, D-72076, Germany|The Netherlands Cancer Institute - Oncology, Amsterdam, 1066 CX, Netherlands|Maxima Medisch Centrum, Eindhoven, 5604 DB, Netherlands|Leiden University Medical Center, Leiden, 2300-RC, Netherlands|Universitair Medisch Centrum Utrecht, Utrecht, 3584 CX, Netherlands|Hospital de La Santa Creu i Sant Pau, Barcelona, 08041, Spain|Hospital Lucus Augusti, Lugo, 27003, Spain|M.D. Anderson Center Madrid, Madrid, 28033, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Universit?tsspital Bern, Inselspital, Bern, 3010, Switzerland|Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland|Kantonsspital St. Gallen, Saint Gallen, 9007, Switzerland|Western General Hospital - Edinburgh Cancer Centre, Edinburgh, EH4 2XU, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom|Mount Vernon Hospital, Northwood, HA6 2RN, United Kingdom|Royal Cornwall Hospital (RCH) - Sunrise Centre, Truro, TR1 3LJ, United Kingdom Less <<
NCT04454762 Hepatocellular Carcinoma PHASE2 UNKNOWN 2024-02-01 Department of Internal Medicin... More >>e I, Johannes Gutenberg University Mainz, Mainz, 55131, Germany Less <<
NCT03685448 Renal Cell Carcinoma|Papillary... More >> Renal Cell Carcinoma Type 1|Papillary Renal Cell Carcinoma Type 2|Chromophobe Renal Cell Carcinoma|Sarcomatoid Renal Cell Carcinoma|Xp11.2 Translocation-Related Renal Cell Carcinoma Less << PHASE2 UNKNOWN 2024-04-30 Border Medical Oncology Resear... More >>ch Unit / The Border Cancer Hospital, Albury, New South Wales, 2460, Australia|Campbelltown Hospital, Campbelltown, New South Wales, 2560, Australia|St George Hospital, Kogarah, New South Wales, Australia|Macquarie University Hospital, Macquarie Park, New South Wales, 2109, Australia|Calvary Mater Newcastle, Newcastle, New South Wales, Australia|Royal Brisbane & Women's Hospital, Herston, Queensland, Australia|Flinders Medical Centre, Bedford Park, South Australia, 5042, Australia|Adelaide Cancer Centre / Ashford Cancer Centre Research / Cancer Care SA, Kurralta Park, South Australia, 5037, Australia|Box Hill Hospital - Eastern Health, Box Hill, Victoria, 3128, Australia|Monash Medical Centre, Clayton, Victoria, Australia|Goulburn Valley Health, as a satellite site under the supervision of Border Medical Oncology Research Unit, via the Tele-trial model, Shepparton, Victoria, 3630, Australia Less <<
NCT02041260 Differentiated Thyroid Cancer ... More >>(DTC)|Poorly Differentiated Thyroid Cancer Less << PHASE2 UNKNOWN 2025-05-22 Abramson Cancer Center of the ... More >>University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States Less <<
NCT04767906 Hepatocellular Carcinoma PHASE2 COMPLETED 2024-07-19 Technische Universit?t Dresden... More >>, Medizinische Fakult?t Carl Gustav Carus Medizinische Klinik und Poliklinik I, Dresden, Saxonia, 01307, Germany|MVZ Mitte/MVZ Delitzsch GmbH, Leipzig, Saxonia, 04103, Germany|University Hospital Leipzig, Leipzig, Saxonia, 04103, Germany|Charite Universit?tsmedizin, Campus Virchow Klinikum, Klinik für Hepatologie/Gastroenterologie, Berlin, 13353, Germany|Universit?tsklinikum Mannheim, Mannheim, 68167, Germany Less <<
NCT01688999 Urothelial Carcinoma|Urethral ... More >>Neoplasms|Urinary Bladder Neoplasms|Kidney Neoplasms Less << PHASE2 COMPLETED 2020-09-14 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<
NCT04524208 Neuroendocrine Tumors|Neuroend... More >>ocrine Carcinoma Less << PHASE2 ACTIVE_NOT_RECRUITING 2024-10-31 Medizinische Universit?t Wien,... More >> Wien, Austria|University Medical Center G?ttingen, G?ttingen, Lower Saxony, 37075, Germany|Zentralklinik Bad Berka GmbH, Bad Berka, 99437, Germany|Universit?tsklinikum Carl Gustav Carus, Dresden, 01307, Germany|Universit?tsklinikum Erlangen, Erlangen, Germany|Universit?tsklinikum Freiburg, Freiburg, 79106, Germany|Universit?tsklinikum Halle, Halle, Germany|Asklepios St. Georg, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Klinikum Heidelberg, Heidelberg, Germany|Universit?tsmedizin Mannheim, Mannheim, Germany|Universit?tsklinikum Gie?en und Marburg GmbH, Marburg, 35043, Germany|Johannes-Wesling-Klinikum Minden, Minden, Germany|Klinikum Ulm, Ulm, Germany|Universit?tsklinik Würzburg, Würzburg, Germany Less <<
NCT05613894 Metastatic Castration-resistan... More >>t Prostate Cancer Less << PHASE1 RECRUITING 2028-05-01 Huntsman Cancer Institute at U... More >>niversity of Utah, Salt Lake City, Utah, 84112, United States Less <<
NCT01639508 Non-Small Cell Lung Cancer PHASE2 RECRUITING 2025-07-26 Memorial Sloan Kettering Baski... More >>ng Ridge, Basking Ridge, New Jersey, 07920, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, 07645, United States|Memorial Sloan Kettering Commack, Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester, Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, 11553, United States Less <<
NCT05100082 Hepatocellular Cancer ACTIVE_NOT_RECRUITING 2025-11-30 Takeda Selected Site, Tokyo, J... More >>apan Less <<
NCT04134390 Old Age; Debility|Renal Carcin... More >>oma Metastatic Less << PHASE2 COMPLETED 2023-11-22 Hospital de Ciudad Real, Ciuda... More >>d Real, Spain|ICO L'Hospitalet, L'Hospitalet De Llobregat, Spain|Hospital Insular de Gran Canarias, Las Palmas De Gran Canaria, Spain|Hospital Lucus Augusti, Lugo, Spain|Hospital Infanta Sofia, Madrid, Spain|Hospital Universitario de Donostia, San Sebastián, Spain|Fundación Instituto Valenciano de Oncologia, Valencia, 46009, Spain|Hospital Doctor Peset, Valencia, Spain|Hospital Universitario La Fe, Valencia, Spain|Hospital Clinico de Valladolid, Valladolid, Spain Less <<
NCT04204850 Hepatocellular Carcinoma|Recur... More >>rent Cancer|Liver Transplant Less << PHASE2 RECRUITING 2025-12-07 Princess Margaret Cancer Centr... More >>e, Toronto, Ontario, M5G 2M9, Canada Less <<
NCT01588821 Lung Cancer|Solid Tumor (Not B... More >>reast or Prostate Cancers) Less << PHASE2 COMPLETED 2025-06-19 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States Less <<
NCT01834651 Prostate Cancer PHASE2 COMPLETED 2016-07-18 Cedars-Sinai Medical Center, L... More >>os Angeles, California, 90048, United States Less <<
NCT03339219 Advanced Renal Cell Carcinoma PHASE2 COMPLETED 2020-08-25 Nagoya University Hospital, Na... More >>goya, Aichi, Japan|Hokkaido University Hospital, Sapporo, Hokkaido, Japan|Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan|Kobe University Hospital, Kobe, Hyogo, Japan|Yokohama City University Hospital, Yokohama, Kanagawa, Japan|Yokohama City University Medical Center, Yokohama, Kanagawa, Japan|Kindai University Hospital, Osakasayama, Osaka, Japan|Osaka University Hospital, Suita, Osaka, Japan|Nippon Medcal School Hospital, Bunkyo-ku, Tokyo, Japan|Toranomon Hospital, Minato-ku, Tokyo, Japan|Keio University Hospital, Shinjuku-ku, Tokyo, Japan|Tokyo Women's Medical University Hospital, Shinjuku-ku, Tokyo, Japan|Kyushu University Hospital, Fukuoka, Japan|Niigata University Medical and Dental Hospital, Niigata, Japan|Okayama University Hospital, Okayama, Japan|Osaka City University Hospital, Osaka, Japan|Osaka International Cancer Institute, Osaka, Japan|Tokushima University Hospital, Tokushima, Japan|Yamagata University Hospital, Yamagata, Japan Less <<
NCT03201250 Multiple Myeloma|Refractory Mu... More >>ltiple Myeloma|Relapsed/Refractory Multiple Myeloma Less << PHASE1|PHASE2 TERMINATED 2021-04-12 University of Nebraska Medical... More >> Center, Omaha, Nebraska, 68198, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States Less <<
NCT04804813 Renal Cell Carcinoma COMPLETED 2024-03-31 Takeda Selected Site, Tokyo, J... More >>apan Less <<
NCT06377722 Renal Cell Carcinoma Metastati... More >>c|Renal Cell Carcinoma Stage IV|Renal Cell Carcinoma Stage III Less << PHASE2 TERMINATED 2022-08-09 Hospital Universitario Central... More >> de Asturias, Oviedo, Asturias, Spain|Institut Català d'Oncologia. Idibell, L'Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario de Valdecilla, Santander, Cantabria, Spain|Hospital Univeristario 12 de Octubre, Madrid, 28041, Spain|Centro Oncológico Clara Campal - HM CIOCC, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario Severo Ochoa, Madrid, Spain Less <<
NCT01703065 Adenocarcinoma of the Prostate... More >>|Castration-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage III Prostate Cancer|Stage IV Prostate Cancer Less << PHASE2 TERMINATED 2015-09-18 Seattle Cancer Care Alliance/U... More >>niversity of Washington, Seattle, Washington, 98109, United States Less <<
NCT01466036 Carcinoid Tumor|Pancreatic Neu... More >>roendocrine Tumor Less << PHASE2 COMPLETED 2025-12-23 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02214, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.99mL

0.40mL

0.20mL

9.97mL

1.99mL

1.00mL

19.94mL

3.99mL

1.99mL

References

 

Historical Records

Categories